Search research articles
Contact Us
Filters
Showing results (141-150 of 168) with videos related to
Page
of 17
Sort By:
Journal of Medicinal Chemistry
|
May 20, 2025
Discovery of an Orally Bioavailable and Brain Penetrant Selective Estrogen Receptor Degrader
Guobao Zhang, Peter Q Huang, Kevin D Bunker, et al.
Radiation Protection Dosimetry
|
September 7, 2011
Distribution, enrichment and principal component analysis for possible sources of naturally occurring and anthropogenic radionuclides in the agricultural soil of Punjab state, India
Ajay Kumar, Vikram M Joshi, Manish K Mishra, et al.
European Journal of Pharmacology
|
February 26, 2009
RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia
Kamna Nanda, Krishna S Naruganahalli, Suman Gupta, et al.
Cancer Research Communications
|
August 12, 2025
A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid Tumors
Kenneth B DeSantes, Kimberly A McDowell, Paul M Sondel, et al.
Journal of Medicinal Chemistry
|
August 23, 2021
Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer
Peter Q Huang, Brant C Boren, Sayee G Hegde, et al.
Structure (London, England : 1993)
|
June 2, 2007
Structure and analysis of FCHo2 F-BAR domain: a dimerizing and membrane recruitment module that effects membrane curvature
William Mike Henne, Helen M Kent, Marijn G J Ford, et al.
Heliyon
|
November 30, 2023
Enhanced O<sub>2</sub>/N<sub>2</sub> separation by QuaternizedMatrimid/Multiwalled carbon nanotube mixed-matrix membrane
Mallikarjunagouda Patil, Savitri G Hunasikai, Shridhar N Mathad, et al.
Endocrinology
|
May 12, 2011
The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation
Xiao Hu, Sarah Du, Cansu Tunca, et al.
Journal of Cardiovascular Pharmacology
|
February 8, 2011
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat
Laxminarayan G Hegde, Cecile Yu, Travis Renner, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Discovery of TD-0212, an Orally Active Dual Pharmacology AT<sub>1</sub> Antagonist and Neprilysin Inhibitor (ARNI)
R Murray McKinnell, Paul Fatheree, Seok-Ki Choi, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 168) with videos related to
Sort By:
Page
of 17
Journal of Medicinal Chemistry
|
May 20, 2025
Discovery of an Orally Bioavailable and Brain Penetrant Selective Estrogen Receptor Degrader
Guobao Zhang, Peter Q Huang, Kevin D Bunker, et al.
Radiation Protection Dosimetry
|
September 7, 2011
Distribution, enrichment and principal component analysis for possible sources of naturally occurring and anthropogenic radionuclides in the agricultural soil of Punjab state, India
Ajay Kumar, Vikram M Joshi, Manish K Mishra, et al.
European Journal of Pharmacology
|
February 26, 2009
RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia
Kamna Nanda, Krishna S Naruganahalli, Suman Gupta, et al.
Cancer Research Communications
|
August 12, 2025
A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid Tumors
Kenneth B DeSantes, Kimberly A McDowell, Paul M Sondel, et al.
Journal of Medicinal Chemistry
|
August 23, 2021
Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer
Peter Q Huang, Brant C Boren, Sayee G Hegde, et al.
Structure (London, England : 1993)
|
June 2, 2007
Structure and analysis of FCHo2 F-BAR domain: a dimerizing and membrane recruitment module that effects membrane curvature
William Mike Henne, Helen M Kent, Marijn G J Ford, et al.
Heliyon
|
November 30, 2023
Enhanced O<sub>2</sub>/N<sub>2</sub> separation by QuaternizedMatrimid/Multiwalled carbon nanotube mixed-matrix membrane
Mallikarjunagouda Patil, Savitri G Hunasikai, Shridhar N Mathad, et al.
Endocrinology
|
May 12, 2011
The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation
Xiao Hu, Sarah Du, Cansu Tunca, et al.
Journal of Cardiovascular Pharmacology
|
February 8, 2011
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat
Laxminarayan G Hegde, Cecile Yu, Travis Renner, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Discovery of TD-0212, an Orally Active Dual Pharmacology AT<sub>1</sub> Antagonist and Neprilysin Inhibitor (ARNI)
R Murray McKinnell, Paul Fatheree, Seok-Ki Choi, et al.
Page
of 17